Save Product
Product Details
Background
Recombinant Monoclonal Anti-PTK7 Antibody, Rabbit (P2A01) is a PTK7 primary antibody for IHC application.
PTK7 is a member of the receptor tyrosine kinase (RTK) superfamily, plays a critical role in regulating cell polarity, migration and tissue homerostasis during vertebrate development. PTK7 can form heterdimers and function as a signal enhancer or co-receptor, deeply involved in the switching of WNT signaling pathway. PTK7 is overexpressed in a variety of tumors, such as cervical cancer, colorectal cancer, breast cancer and so on, where it is closely associated with tumorigenesis and progression.Product Specifications
Host SpeciesRabbitIsotypeRabbit IgG, Rabbit KappaCloneP2A01ApplicationIHC-PDilution Ratio1: 100 - 1: 500FormLiquidClonalityMonoclonalReactivityHumanSynonymsCCK4Concentration0.9~1.1 mg/mlSpecificityReact with PTK7 protein on the membrane of target cell/tissuePurification TechFc-TagPreservationPBS, 11% Trehalose, 40% Glycerol, 0.03% Proclin 300, 0.05% BSAExperiment Protocol
Storage
Shipped at 4°C, Blue Ice. Store at +4°C for short term (1-2 weeks). Store at -20°C for long term.
Avoid freeze / thaw cycle. Upon delivery aliquot. The shelf life is 30 days from the date of opening.ACRO Quality Management System
Customers Also Viewed
Performance Data
Sample Staining Data
Immunohistochemical analysis of paraffin embedded human cervical cancer labelled with HGS-M2715 at 1/200 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with LEICA BOND IHC staining protocol.
Immunohistochemical analysis of paraffin embedded human uterus tissue labelled with HGS-M2715 at 1/200 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with LEICA BOND IHC staining protocol.
Customer Reviews Writing Reviews
Recent Advances
Drug Development Progress- English Name：
Protein-tyrosine kinase 7
- Category：
- Approved Drugs：
0 Details
- Drugs in Clinical Trials：
8 Details
- Highest Development Stage：
Phase 2 Clinical
Contact Us
Drug Candidate Licensing
